Close

Jump to:

  • Navigation
  • Content
  • Footer
Famli hero image

Famli

Follow

Famli is transforming how families look after their wellbeing for the growing $136bn parent-tech market.

205%
 - 
Funded 25 Jul 2022
£70,000 target
£144,112 from 212 investors
More
Less

Business overview

Location Bristol, United Kingdom
Social media
Website www.famlikids.com/
Sectors Healthcare Digital B2B
Company number 12594370
Incorporation date 11 May 2020
More
Less

Investment summary

Type Equity
Valuation (pre-money) £1.1M
Equity offered 11.62%
Share price £0.96
Tax relief

SEIS

More
Less

Business highlights

  • No.1 solution chosen by clinicians to prevent childhood obesity in Sweden
  • Endorsed and funded by Innovate UK
  • Used by primary schools across the UK, with LOI’s for purchase
  • Famli app launched in Aug 2021 and generating revenues
More
Less

Key features

  • Secondary Market
  • Nominee investment min. £10.56 +
  • Idea
  • Investor Perks
  • Team
  • Updates
  • Investors 212
  • Discussion
  • Documents

Idea

Introduction

Family life can be challenging.

Now more than ever, wellbeing is a crucial aspect of life that needs to be nurtured and improved.

Famli's vision is to disrupt the digital health industry focused on individuals, and build a world in which more families wake up feeling healthy and happy.

Researched with over 3300 families, Famli makes it fun and simple for parents and young children to easily exercise more, eat better and improve their mental health - all from one place. It does this by combining over 200 intergenerational wellbeing activities, with engaging gamification features.

Famli's positive impact:

The parent-tech market is growing fast and the school wellbeing curriculum is more important than ever. We aim to improve the mental and physical health of pupils through modernising education. Famli’s route to market strategy is to licence its platform to primary schools, enabling them to positively impact their pupil’s wellbeing beyond the classroom - all the way to their families.

Substantial accomplishments to date

• Famli has been crowned by clinicians as Sweden’s number one solution to preventing childhood obesity by 2030.

• Our app has been researched with over 3300 families for 2 years, producing results showing a clear positive influence of the wellbeing of families with young children (available upon request).

• In just 4 months, over 20 schools are already interested in using Famli as a pupil wellbeing tool, and we have received various letters of intent.

• We are endorsed and funded by the UK's national innovation agency, Innovate UK.

• The Famli app was launched onto both the Google Play Store and Apple’s App Store in August 2021,

• Over 9,000 families have downloaded our app, with a 5-star overall rating in the app stores.

• Families are sharing the app on social media, organically growing our user base.


• Established a well-balanced founding team, with experienced advisors from the likes of Innovate UK, Montessori and SWELife.

• Founders awarded both the UK Young Innovator Award & Santander Entrepreneurship Award

• We became KidSAFE Certified, through adhering to unique and high standards for online child safety.

• Due to the positive impact we’re making, we’ve received media coverage from The BBC, Business Live, Tech Round, Bristol Live and B24/7.

Monetisation strategy

We are currently focused on licensing our digital wellbeing solution to Primary Schools. Famli plans to charge an annual licence fee of £10 per pupil, this averages to £2500 per school in the UK.

With English school spending on mental health support almost doubling in the last 3 years, and the UK government announcing a £17million support package to improve pupil wellbeing in schools, there are significant resources available to schools to purchase Famli.

The UK market alone has over 20,000 primary schools, creating a potential revenue pool of over £50 million ARR. After establishing ourselves in the UK, our ambition is to expand internationally from 2024. Even if we sold to just 5% of primary school age children across the world, this would create roughly £350 million in ARR.

In the longer term (4-5 years), we aim to build upon our B2C subscription based sales channel, deploying Famli to corporate organisations as an employee benefit and working with health insurance companies.

Use of proceeds

With a researched and tested product, technology already built, working relationships in the school sector and a passionate and focused team, we plan to use the investment in two core areas to supercharge our growth. These areas are:

1. Product Development - Our roadmap for the next 12 months consists of implementing essential features for school usage. These include building a teacher portal for school staff to monitor pupil progress and expanding the usability of the app onto tablets and iPads.

2. School Sales Channel Expansion - Developing and increasing the number of our school pilots while collecting further valuable statistical data on our positive impact, will enable us to convert multiple school licensing sales, for upcoming national and international scaling in 2023.

For further information, our available documents include a detailed breakdown on the use of proceeds.

Join us and be part of the future of family and children health!

Investor Perks

Please note that any discounts, rewards and/or offers listed by a company in its campaign are subject to the terms and conditions applied by that company and listed above. It is the company’s responsibility to honour such discounts, rewards and/or offers and Seedrs does not take any responsibility for them.

Open an account to get access to the team members of Famli

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for Famli has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 27 May 2022 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £1,094,880

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Nominee investment

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Nominee investment.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Nominee investment). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Security Token

A security token is a digital asset that represents ownership or other rights. It is a digital form of traditional investments. In the future, you may be able to trade your investment through compatible exchanges.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel